In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Assistant Professor Evangelos Giannitsis
Evangelos Giannitsis Evangelos Giannitsis

University Hospital of Heidelberg, Heidelberg (Germany)

Speciality : Acute Coronary Syndromes

Assistant Professor of Medicine in Heidelberg. After gaining his medical degree from the University of Homburg, Prof. Giannitsis completed postgraduate training in internal medicine and cardiology at Lübeck University Hospital, Germany. Subsequently, he undertook a PhD in internal medicine before his current position in 2002. Prof. Giannitsis’s research interests focus on cardiac biomarkers, i.e. troponins, and their validation in the diagnosis of coronary syndromes, as well as cardiac MR imaging. He has been the Principal National Coordinator in many clinical trials in these fields including the PLATO trial, the ATLAS-TIMI 46 and ATLAS-TIMI 51 trials. He is a member of numerous professional societies including the European Society of Cardiology: He served as a member of the program committee for the ESC from 2010-2012, and he is a founder of the Chest Pain Unit initiative of the German Society of Cardiology and currently the Chair of the certification committee for Chest Pain Units.

15 presentations from this speaker

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - CON.

Event : Acute Cardiovascular Care 2021

  • Session : The 2020 NSTE - ACS guidelines in practice – the pros and cons
  • Speaker : E Giannitsis (Heidelberg,DE)

Diagnostic pitfalls: separating myocardial infarction from injury.

Event : Heart Failure 2019

  • Session : Acute heart failure and acute coronary syndrome
  • Speaker : E Giannitsis (Heidelberg,DE)

Discussion - Cardiac biomarkers in the acute setting, from diagnosis to risk prediction.

Event : Acute Cardiovascular Care 2019

  • Session : Cardiac biomarkers in the acute setting, from diagnosis to risk prediction
  • Speaker : M Moeckel (Berlin,DE), B Lindahl (Uppsala,SE), R Twerenbold (Basel,CH), E Giannitsis (Heidelberg,DE), L Wallentin (Uppsala,SE)
  • Sponsored by Roche Diagnostics International Ltd.

Implementation of the ESC 1-hour algorithm for the evaluation of chest pain.

Event : Webinar 2019

  • Session : ACVC Webinars 2019
  • Speaker : E Giannitsis (Heidelberg,DE), CE Mueller (Basel,CH), R Twerenbold (Basel,CH)

New biomarkers, diagnosis and risk-stratification.

Event : Acute Cardiovascular Care 2019

  • Session : Pulmonary embolism: State of the Art in 2019
  • Speaker : E Giannitsis (Heidelberg,DE)

The latest and greatest from the Heidelberg registry study.

Event : Acute Cardiovascular Care 2019

  • Session : Cardiac biomarkers in the acute setting, from diagnosis to risk prediction
  • Speaker : E Giannitsis (Heidelberg,DE)
  • Sponsored by Roche Diagnostics International Ltd.

Two separate decisions: rule-out of AMI and discharge from the Emergency Department.

Event : Acute Cardiovascular Care 2018

  • Session : Safe rule-out and rule-in of AMI
  • Speaker : E Giannitsis (Heidelberg,DE)

Do cardiac troponin T -high sensitive gender specific cut-offs lead to different treatment strategy for the diagnosis of AMI?

Event : ESC Congress 2017

  • Session : How to use biomarkers to optimize diagnosis and risk stratification of acute coronary syndrome (ACS)
  • Speaker : E Giannitsis (Heidelberg,DE)
  • Sponsored by Roche Diagnostics International

Fast & immediate rule out strategy in patients with suspected ACS –strengths and limitations.

Event : Webinar 2017

  • Session : ACVC Webinars 2017
  • Speaker : E Giannitsis (Heidelberg,DE), K Huber (Vienna,AT), M Moeckel (Berlin,DE)

State of the Art: chest pain in the emergency department: biomarkers, how and when

Event : ESC Congress 2017

  • Session : Chest pain in the emergency department: the "Biomarkers-Versus-Imaging-Dilemma"
  • Speaker : E Giannitsis (Heidelberg,DE)

Coronary interventions associated with myocardial injury or myocardial infarction.

Event : Acute Cardiovascular Care 2016

  • Session : How to interpret troponin elevations beyond ACS
  • Speaker : E Giannitsis (Heidelberg,DE)

Non-invasive imaging for CAD: are we there?

Event : ESC Congress 2016

  • Session : How to combine biomarkers and imaging in CAD
  • Speaker : E Giannitsis (Heidelberg,DE)
  • Sponsored by Singulex Inc

Should we adopt gender and age specific troponin cut offs?

Event : Acute Cardiovascular Care 2016

  • Session : The use of biomarkers in ACS and heart failure
  • Speaker : E Giannitsis (Heidelberg,DE)

How markedly elevated initial high-sensitive cardiac troponin T value predicts acute myocardial infarction in patients with acute chest pain.

Event : ESC Congress 2015

  • Session : How to use high-sensitive cardiac troponin T to accelerate the diagnosis of acute myocardial infarction: results from a prospective multicenter study
  • Speaker : E Giannitsis (Heidelberg,DE)
  • Sponsored by Roche Diagnostics

How to manage patients with abnormal troponin values.

Event : Acute Cardiovascular Care 2015

  • Session : Acute cardiovascular care in the elderly
  • Speaker : E Giannitsis (Heidelberg,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are